YouSaid · the spoken record

Joe Green

lines on the record: 45
first: 2024-01-18
most recent: 2024-01-18
sittings or episodes: 1
sources: podcast

Every line below is reproduced as it was said and linked to the record it came from. Nothing here is summarised or generated. Directory · Search · Corrections

“Very judgmental and very people are valued based on how big of an impact they're having. And look, it's hard to know how much you've changed. And that's why it's great to have friends over periods of time. And I get a lot of positive feedback that I am a more patient, more empathetic person. And I think this is not just psychedelics. It's meditation. It's a whole variety of things together.”
2024-01-18 · On with Kara Swisher · Psychedelics with Joe Green · IDENTIFIED FROM THE TRANSCRIPT
“I still am afraid of death. I think I am less so. I think it is less present in my experience. And I think that my orientation of the purpose of life is very different. I think it used to be.”
2024-01-18 · On with Kara Swisher · Psychedelics with Joe Green · IDENTIFIED FROM THE TRANSCRIPT
“And I do think a big part of the spiritual journey is just learning how to be in normal life experience. And I think these heightened states. One of my friends said this to me early in my psychedelic journey they can show you like high notes, like band MDMA can show you what it's like to feel love in a very extreme way. And the right response from that is not to do MDMA all the time, it's to notice in your life, okay, when am I feeling that a little bit? It makes you more self-aware and more able to tune around it. But in the end of the day.”
2024-01-18 · On with Kara Swisher · Psychedelics with Joe Green · IDENTIFIED FROM THE TRANSCRIPT
“But I don't think it's gone. And I certainly have some graspiness towards that. And it's funny, one of my very good friends, Paul, who's a very serious meditator just this morning, texted me this quote that's been sitting me preferencing expansion over contraction is contracting around expansion. And I think I can get very, people can get very graspy and contracted around wanting to have expanded states. And I think there is while the sort of classic psychedelics are not physically addictive and don't show kind of normal addiction properties, I do think that like you can get in a place where it's like, well, I could go to a walk in the woods or I could go on the walk in the woods and acid, and that would be like more beautiful.”
2024-01-18 · On with Kara Swisher · Psychedelics with Joe Green · IDENTIFIED FROM THE TRANSCRIPT
“It's a great question. Yes, I mean, I have a number of friends who have had experiences with psychedelics where they come out saying I no longer fear death. I've seen my own death. I've experienced it. I've merged into the consciousness. My own guided psychedelic journeys, many of them have been between difficult and terrifying. I have felt like I went through layers of Dante's Inferno. They have not all been like fun by any means. And I think it's important for people to understand, like, I think that my fear is lessened. And I've had some experiences of touching death.”
2024-01-18 · On with Kara Swisher · Psychedelics with Joe Green · IDENTIFIED FROM THE TRANSCRIPT
“Often it was actually the guy who would take the substance, not the client, and then they would heal you while they were on the substance. But they would only allow people to take them after, you know, studying and being part of a tradition. They weren't just kind of like offered out there. The same way I'm Jewish, you were not allowed to study Kabbalah until you were 40, married, and had kids. And I think it's really important to have reverence for these substances and to treat them as the powerful serious things that they are.”
2024-01-18 · On with Kara Swisher · Psychedelics with Joe Green · IDENTIFIED FROM THE TRANSCRIPT
“A view of a serious condition, depression, PTSD, et cetera, it's particularly important to do in a guided context unless you have expert guidance, start with small amounts. Dosage matters. A fourth thing, super simple, don't go solo. Have a friend with you who's sober psilocybin, as far as we know, cannot kill you physically, but you could run into traffic and get hit by a car. Sure. So if you have a friend with you who's keeping an eye on you, it helps a lot. And then the last thing is, and I think this is important, which is having reverence that these are very powerful substances. I mean, if you look at the psilocybin research, people describe dying, meeting God. They describe it as the most profound experience of their life. In indigenous cultures,”
2024-01-18 · On with Kara Swisher · Psychedelics with Joe Green · IDENTIFIED FROM THE TRANSCRIPT
“So I think on the potency side, it's actually to me fascinating because in the FDA trials of psilocybin, they use synthetic psilocybin, which is very precise. Natural occurring mushrooms have varying amounts of psilocybin, but the law is written in terms of milligrams of psilocybin, not grams of mushrooms. And so they actually have had to do a bunch of potency testing and learn a bunch, and now they have pretty good potency testing in Oregon to know, okay, this is the right amount to offer people. And so I think through this regulated model, people are getting smarter. They have a guide who can tell them what to do. And look, I think, again, this is why honest education is so important. They're not from everyone. If you have a personal or family history of schizophrenia or a bipolar or taking certain medications, you shouldn't do it.”
2024-01-18 · On with Kara Swisher · Psychedelics with Joe Green · IDENTIFIED FROM THE TRANSCRIPT
“It's a great point. So, A, I should say that our group, like we do not believe that there should be mushroom stores in the way that there are cannabis stores. We think that these are best used in this guided context. And one of the many reasons we decided to support Oregon was realizing if we didn't shape what was happening, it was going to happen in a worse way.”
2024-01-18 · On with Kara Swisher · Psychedelics with Joe Green · IDENTIFIED FROM THE TRANSCRIPT
“I think what we're trying to balance is get as many people towards the legal, regulated access and also say, look, if you're doing it underground, which is happening, it's happened for a long time, it's going to continue to happen, let's at least have it in the light of day. So if something abusive happens, people can go to the authorities without worry of being arrested. Sure. So I think the view is like this stuff is already happening. Let's try to.”
2024-01-18 · On with Kara Swisher · Psychedelics with Joe Green · IDENTIFIED FROM THE TRANSCRIPT
“Totally. So just to be clear, Colorado, the ballot shit of the past in Colorado does two things primarily. It creates a regulated access system very similar to Oregon, although it offers more plant medicine. So in addition to psilocybin in the future, they will look at Iboga or Ibogane and mescaline cactus. Those are all naturally occurring psychedelic compounds. They also did sort of this decriminalization of possession of these same compounds. Now I should say that, you know, I don't control the drafting of the ballot initiatives. It was done by this group new approach, certainly we're in close relationship with them. Part of this was driven by sort of local activists who cared a lot about the decrim and it was part of it was the political negotiation to put the coalition together. You know, I think we can probably all agree that somebody growing mushrooms in their basement and eating”
2024-01-18 · On with Kara Swisher · Psychedelics with Joe Green · IDENTIFIED FROM THE TRANSCRIPT
“Think it's actually more efficacious because of the community. And I think it's also abuse potential, right? You have eight people in a room with a therapist. It's much harder for something untaught to happen.”
2024-01-18 · On with Kara Swisher · Psychedelics with Joe Green · IDENTIFIED FROM THE TRANSCRIPT
“I think that's helpful. And I think another piece is group therapy. So we've heard a lot about the maps model of the two therapists, one patient. But in most Indigenous use over history, it's been groups of people. And one of the things that's exciting to me about the Oregon model is it allows for group experiences. And the Jervison, so you talked about before have funded a pilot in Oregon. So there's a nonprofit called Heroic Hearts, which works with veterans. And they've taken veterans to Jamaica and Peru to receive psilocybin or ayahuasca treatment. And I just want to say it is a national embarrassment that our veterans have to go overseas when our government has like won't provide the”
2024-01-18 · On with Kara Swisher · Psychedelics with Joe Green · IDENTIFIED FROM THE TRANSCRIPT
“In the Oregon system, there's, I think, about 200 license facilitators thus far. Now, they're not all practicing yet because there's a shortage of service centers. And the service centers have been holding, as far as, and I visited a few of them quite a high bar. And they have to go through state licensure, and then they have to get a service center that's going to hire them. But in Oregon, The criteria is lower. You don't have to be a licensed therapist. You need to just have a high school degree and go through one of these training programs and then have some supervised time and be hired by or partner with a service and they're not often not employees. And it's really trying to find this balance between access and safety.”
2024-01-18 · On with Kara Swisher · Psychedelics with Joe Green · IDENTIFIED FROM THE TRANSCRIPT
“What, look, I think there is this important compared to what question, right? Nothing is 100% safe. The self-driving cars is a great example of that. So some of it is public education about like, and there's trade-offs, right? Like the harder you make signed access. Like it's easy to hear about the person who was abused and forget about the person who killed themselves because they didn't have access to treatment. Sure. And so that's what you're balancing.”
2024-01-18 · On with Kara Swisher · Psychedelics with Joe Green · IDENTIFIED FROM THE TRANSCRIPT
“And with psychedelics, as you point out, people are even more vulnerable. So I think the two therapist model is a way to do that. Obviously, another really important thing, which PSFC has support, is the creation of certification boards and professional associations. So if you're a licensed therapist and you have consensual sex with a client, as far as I know, you have not committed a crime, but you will lose your license. And so the licensure board and the professional association is a way that behavior is regulated. So actually the same guy I mentioned, Mike Cotton, pointed us to, look, if you want reimbursement, companies have to know who's a qualified practitioner. And so we have supported financially and with expertise a number of our members setting up a professional association and a licensing board in the psychedelic space.”
2024-01-18 · On with Kara Swisher · Psychedelics with Joe Green · IDENTIFIED FROM THE TRANSCRIPT
“Yeah, I mean, it's when I first started to hear about this, I remember Googling, you know, what percentage of just normal therapists have sex with their patients. And like anonymous survey said something like 10%. And so it is a very common thing, which is pretty scary to think about. And so it is.”
2024-01-18 · On with Kara Swisher · Psychedelics with Joe Green · IDENTIFIED FROM THE TRANSCRIPT
“Might be able to be like in training or something. And the two is also a great way to prevent abuse because you have two people in the room”
2024-01-18 · On with Kara Swisher · Psychedelics with Joe Green · IDENTIFIED FROM THE TRANSCRIPT
“Maps has a training program and they're working with other educational institutions. And now we don't exactly know what FDA will say. And the tricky thing is FDA actually doesn't regulate therapy. They regulate drugs. So we don't know what they will or won't say. But I think the expectation is that MAPS currently has a two therapist model and the expectation is at least one of them will have to be a licensed social worker therapist psychologist psychiatrist. The other might.”
2024-01-18 · On with Kara Swisher · Psychedelics with Joe Green · IDENTIFIED FROM THE TRANSCRIPT
“So it depends under what system. So under the FDA regulated system, the only guides are the ones that have been part of the clinical trials. And Lycos has been offering educational training to guides. That's going to be the big gating mechanism once the treatment's approved. The hard sort of growth problem is that guides need to have experience guiding people in order like the way medical training works is you do residency, right? You need to be, if you're a therapist, you need supervision hours. And that, except in a clinical trial, that hasn't been able to happen thus far because there's been no legal way to do it.”
2024-01-18 · On with Kara Swisher · Psychedelics with Joe Green · IDENTIFIED FROM THE TRANSCRIPT
“Yeah, so I'm excited about our prospects in California. So I'm a native Californian. California is sort of the psychedelic capital of the universe. And what Newsom has said is that he is very open to approving a regulated access system, which is like the Oregon system. And so there is an effort underway in California, bipartisan effort, to put a bill up. And it would be the first time if it passes to do an Oregon-like bill through a legislature. Oregon, Colorado, were both done with ballot initiatives. And so I think we can through the legislative process, which allows more iterative than a ballot initiative, we can get to sign that really takes into account public education, like actually having some budget there to educate the public about what these are and how to safely access them, et cetera. I agree with Newsom, and I'm excited that we're going to work with the governor's office to try to get a really good bill through.”
2024-01-18 · On with Kara Swisher · Psychedelics with Joe Green · IDENTIFIED FROM THE TRANSCRIPT
“A talk therapist without having a doctor tell us that there's something wrong. And I think that mental health is much more of a spectrum. It's not like, you know, you're kidney failing. And so one thing I think that's very cool about A whole variety of types of care. Somebody who is in hospice who's on their deathbed with existential distress, people with addiction, et cetera. The guides have to go through a training program. They have to pass a state test. Now, there is a real trade-off that I want to be honest about between safety and access, right? The more safety requirements, the more training requirements you put in, the more expensive it's going to be. And so we've tried to find this right balance. And I think we've over-indexed on safety to start with because this is so new.”
2024-01-18 · On with Kara Swisher · Psychedelics with Joe Green · IDENTIFIED FROM THE TRANSCRIPT
“Yeah, so let me start with Oregon because it's where it starts. And so in Oregon, the Oregon Health Authority issues several types of licenses. So they license the facilitator, who's their term for the guide. They license the producers of the mushrooms and testing labs to test their potency. And they license the service centers, which are the physical locations. Oregon, it is different than FDA, right? So when hopefully MD may assist arapy for PTSD is approved, you will need a PTSD diagnosis and you will have to be in a medical context. In Oregon, anybody can go to Oregon and say, I would like to have a guided psilocybin experience. Now, there is health screening to make sure if you're, say, schizophrenic that you'll be told that that's not a good idea. But just like therapy, right, you and I can go.”
2024-01-18 · On with Kara Swisher · Psychedelics with Joe Green · IDENTIFIED FROM THE TRANSCRIPT
“Complicated and they're federally illegal, state legal. It's incredibly complicated. And so having people that are sophisticated go in. So anyway, I think what I would say to that accountability question is it's each of the organizations has their own boards of directors, in many cases their own outside regulators.”
2024-01-18 · On with Kara Swisher · Psychedelics with Joe Green · IDENTIFIED FROM THE TRANSCRIPT
“So much of the work has been setting up a regulated program. So, for example, in Oregon, the governor of Oregon appointed an advisory panel. It sits under the Oregon Health Authority. So, you know, it's hard because this is Oregon has treated about 750 people in the last six months. And they're also totally inventing all of this from scratch. And so the regulators are doing their very best and I think are doing a great job, but are creating an entire ecosystem of care from scratch. And it's one of the things I most when people ask me, how can I be helpful in the ecosystem besides philanthropic donations, I say, go get involved in creating a business in Oregon because there's so little operational experience in this field. And these service centers, which is what they call the kind of clinics in Oregon, are incredibly...”
2024-01-18 · On with Kara Swisher · Psychedelics with Joe Green · IDENTIFIED FROM THE TRANSCRIPT
“Well, the first thing I would say is I've made a decision to make no psychedelic investments. And I'm a donor in the space. I don't receive a salary from PSFC. So this is done as a volunteer. And I've made no personal investments in the space and plan not to. Everybody on the Maps nonprofit board has decided to not receive any equity in the Lycos, the for-profit, so that we can be the sort of nonprofit stewards. So to sort of answer that part of it. In terms of accountability bodies, I mean, I guess I'm not entirely sure what the question is.”
2024-01-18 · On with Kara Swisher · Psychedelics with Joe Green · IDENTIFIED FROM THE TRANSCRIPT
“Well, I can compare and contrast that if you want to, but I think secondly, the point is that That we were really able to deploy philanthropic capital elsewhere. There's a non infinite amount of philanthropic capital that early stage research, those state initiatives, those are never going to get for-profit funded. And so we wanted to redeploy that capital. And then third, I think this is really important. If Lycos is able to create a good business model, that's going to bring lots of other pharmaceutical companies into the space, which I think is a good thing because I think that like it or not, we live in a capitalist system. Most stuff gets done by for-profit companies. And so let's try to set up this ecosystem where it's actually investable.”
2024-01-18 · On with Kara Swisher · Psychedelics with Joe Green · IDENTIFIED FROM THE TRANSCRIPT
“And it was just announced on Friday that Maps's subsidiary drug company, Maps PBC, which is now called Lycos Pharmaceuticals, raised a hundred million dollar equity financing round. And that was a long process where when we raised this $30 million capstone campaign, we're partnered with Tim Ferris. We did this amazing matching campaign, we thought, okay, that's going to get us through phase three, and then we're going to need to raise more money to actually deliver care. And that then got us to a place where we could see what the revenue model would look like and had to make a choice. Do we continue funding this philanthropically or do we move to for-profit funding? There was a combination of factors as to why we, and I'm on the board of MAPS, I should say, on the parent nonprofit. And the reason we made the decision was one, our number one mission is getting this treatment delivered to people.”
2024-01-18 · On with Kara Swisher · Psychedelics with Joe Green · IDENTIFIED FROM THE TRANSCRIPT
“So, what I was saying in that quote is that I think it's mission creep to totally revolutionize capitalism for psychedelics. I think that so my view of what philanthropy should fund in general is basically two criteria. One, if for-profit is not interested and it's important for it to happen.”
2024-01-18 · On with Kara Swisher · Psychedelics with Joe Green · IDENTIFIED FROM THE TRANSCRIPT
“Yeah, I mean, and again, I want to distinguish our members have given lots of might of research. Then there's the stuff that myself and Graham and our staff have like chosen to focus on. Like, my view is that, okay, MDMA was entering phase three, and we need to make sure it gets approved. If it doesn't, that's a huge problem for the movement. And this is, you know, 13 million Americans of PTSD, a million veterans, like it's hugely important. And then once we learn more, realized, oh, this getting approved is not enough to actually get at treating people. So there's all this stuff that has to happen to build this delivery of care system. And so to me, it was like that seems more important than early research on new substances that are 20 years out from being offered to patients. Now that, maybe that's a bias, that is a perspective. It's certainly not the only perspective. And we've had lots of researchers speak at our events, lots of our members support those researchers. And I am very happy when the research gets funded.”
2024-01-18 · On with Kara Swisher · Psychedelics with Joe Green · IDENTIFIED FROM THE TRANSCRIPT
“Terrible idea. We need to make sure this doesn't happen because why politicize something that is kind of sailing through FDA right now? But as we dug in and realized they were serious people, we did the polling and we thought about it. A sister group called New Approach, which is PAC, is worth a 501c3. And Graham Boyd, who's my co-founder, ran the vast majority of the marijuana ballot initiatives. And so decided to pass this Oregon initiative, which was successful in 2020, followed in 2022 with a similar initiative in Colorado. And now we have one in Massachusetts.”
2024-01-18 · On with Kara Swisher · Psychedelics with Joe Green · IDENTIFIED FROM THE TRANSCRIPT
“It's a great, great question. And anybody who's given a significant amount philanthropically in the psychedelic space is welcome to join PSFC. And we also then form a point of view. And we form that point of view, often driven by our members. But I would say our North Star has been what is going to get safe access to the most people as quickly as possible. So for example, we chose MDMA because it was the furthest along, right? It was the one that was the closest and needed help over the edge. The second big thing that we've focused on, which was really unexpected, has been this state-regulated model starting in Oregon. Two therapists who were married, one sadly passed away, Tom and Cherie Eckert, wrote a ballot initiative to create legal, regulated access to psilocybin mushrooms in Oregon. And when we first heard about it, to be honest, we were like, this is a terrible.”
2024-01-18 · On with Kara Swisher · Psychedelics with Joe Green · IDENTIFIED FROM THE TRANSCRIPT
“It's a collaborative of philanthropic funders. And then the funders share information and bring ideas to each other. And then we also have a small staff that does research to try to figure out, you know, how can we get smarter together and figure out what are the most impactful things to donate to?”
2024-01-18 · On with Kara Swisher · Psychedelics with Joe Green · IDENTIFIED FROM THE TRANSCRIPT
“Right, this is an entirely new modality of care. It's psychedelic plus therapy. And there's never been like a drug therapy combination treatment before. It fundamentally changes the way therapists practice. They go from 45 minute sessions to eight hour sessions. They need to partner with a doctor that's going to prescribe the drug.”
2024-01-18 · On with Kara Swisher · Psychedelics with Joe Green · IDENTIFIED FROM THE TRANSCRIPT
“And at the conference maps announced that they were going to, we were about to embark on phase three, the final phase of FDA trials. And to me, that seemed like a linchpin moment. And I got invited to a dinner at a home in a big mansion in Seacliff in San Francisco. And I tend to be pretty direct. And I started asking, well, who's going to pay for this thing? And everyone's like, well, I'm doing this amount. What about that guy? And there was like 10 people in the whole ecosystem that had given over a million dollars to psychedelics. And I thought, okay, well, maybe I can help with that. And so the initial goal was raise the funds to get maps approved with FDA. Now, as we start doing due diligence, we realized there was a lot more to that. They really had to build a pharmaceutical company. They had to not just get the drug approved. They had to also get it into patient care. And I think that's a really tricky thing here because this is not just a new drug sold at Walkgreen.”
2024-01-18 · On with Kara Swisher · Psychedelics with Joe Green · IDENTIFIED FROM THE TRANSCRIPT
“Yeah, and I heard him talk about taking MDMA through the FDA. And I was like, oh, that's like a, you know, I don't, I didn't think it could happen through like Congress. That's a really clever idea. And then in 2017, I heard about the psychedelic science conference in Oakland. And I just showed up. And it was like I found this buried treasure. There were all of these scientists from Hopkins and UCLA and NYU with all these studies showing these incredible results for people with end-of-life anxiety with depression, with addiction. And I was like, I think I want to help, but I'm not a scientist. I don't know anything about pharmaceuticals.”
2024-01-18 · On with Kara Swisher · Psychedelics with Joe Green · IDENTIFIED FROM THE TRANSCRIPT
“Think for me, like, and this is going to sound maybe overly idealistic, but I want people to be nicer to I would say at a core, that is what I hope for. And I got exposed to this. I met of all things I met Rick Doblin on the summit at Sea Cruise Ship, which is a very bizarre event.”
2024-01-18 · On with Kara Swisher · Psychedelics with Joe Green · IDENTIFIED FROM THE TRANSCRIPT
“I had an opportunity to take a sabbatical for the first time. This was in 2014. And I just decided I'm going to ask everyone I know what are the best personal growth personal learning things that I can try. I went on my first silent meditation retreat. It was kind of like a, you know, a tech stereotype, my first meditation retreat and landmark forum and I did long backpacking trip and I had my first guided psychedelic experiences both with MDMA, with ayahuasca. And these are, unfortunately, these are ineffable experiences, kind of by definition that are very hard to describe. But I think one of the things for me was realizing I had become so intent on like denting the universe that I forgot about appreciating the universe. Like holy crap, we get to have senses.”
2024-01-18 · On with Kara Swisher · Psychedelics with Joe Green · IDENTIFIED FROM THE TRANSCRIPT
“I was a serious kid. If you want to. Dig through, there's a CNN documentary called Kids Under Pressure from when I was 17, where I'm a very, very intense, very pimple-covered teenager. And it really drove me to feel like I need to leave my mark. I need to be remembered. I also said a lot of trouble making friends. I felt like I was made fun of a lot and I kind of needed to prove myself. And that really and the models I looked up to were people who were political and social change agents. And it seemed like, okay, the way that you have a positive impact and make your mark on history is through social change. And that led me into the first part of my career, which is building technology companies around nonprofits and political campaigns. And then after a tragically failed effort to pass integration reform.”
2024-01-18 · On with Kara Swisher · Psychedelics with Joe Green · IDENTIFIED FROM THE TRANSCRIPT
“One of my favorite parts about doing this work is I get to have a lot of conversations where people tell me about their personal healing journeys. And it's a great way to get to know somebody. So I'll share a little bit, not to make it too much about me. But yeah, as you said, when I was a very small child, some of my first memories, I would wake up from naps and then, you know, in that kind of liminal space between awake and asleep. And I would, for some reason, I have no idea why I would contemplate, wow, someday I'm never going to wake up.”
2024-01-18 · On with Kara Swisher · Psychedelics with Joe Green · IDENTIFIED FROM THE TRANSCRIPT
“The things that we're giving people, you know, SSRIs are certainly helpful for some people, but we're treating symptoms. And so I think that people that are entrepreneurs that are used to looking for new solutions have gravitated to something. And it's also a sign that has been overlooked for, frankly, dumb reasons.”
2024-01-18 · On with Kara Swisher · Psychedelics with Joe Green · IDENTIFIED FROM THE TRANSCRIPT
“And look, every technology has pros and cons as you discuss frequently here. And I think that what I think is exciting people about psychedelics, one of the longstanding researchers, Ben Cessa, said once that mental health today is where we were with physiological health in 1900. We can treat some symptoms, but we don't cure anything. And psychedelics are like the invention of antibiotics. And so I think people see certainly what attracted me to the space and they see current mental health is one of the only areas of health where we spend more money and it's getting worse, right? Oncology, cancer, we spend more money and it's getting better. But 1.6 million Americans in 2022 tried to kill themselves. Every day veterans commit suicide. And so I think people get the scale of this crisis and how”
2024-01-18 · On with Kara Swisher · Psychedelics with Joe Green · IDENTIFIED FROM THE TRANSCRIPT
“Yeah, I mean, so the group that I co-founded, the Psychedelic Science Funders Collaborative, consists of about 130 philanthropists who are kind of major givers in the space. And so I can speak kind of with some specific knowledge about what I think has gotten them into the space. And some are tech, but plenty of them are not tech as well. And what seems to be universally true is that everyone has either had a personally healing psychedelic experience, a healing psychedelic experience of a family member, or a tragically knows somebody who killed themselves or died of an overdose without having access. And then the second thing I think is In certain ways, they're a new technology. And I think people in Silicon Valley tend to gravitate towards things that seem like a big leveraged kind of unlock.”
2024-01-18 · On with Kara Swisher · Psychedelics with Joe Green · IDENTIFIED FROM THE TRANSCRIPT
“I mean, I think it doesn't seem to have set us back with the FDA. I mean, the FDA luckily is really looking at evidence and MDMA assisted therapy for PTSD. The drug was just submitted to FDA after two very successful phase three trials where in one trial, 67% and the other one 71% of people went for moderate or severe PTSD to having no diagnosable PTSD. And that's just amazing. And I think that it just reinforces the need for that safe therapeutic container, right? So I think when these stories happen, it just reinforces how important it is to have good regulated legal access so that people are not turning to more dangerous uses.”
2024-01-18 · On with Kara Swisher · Psychedelics with Joe Green · IDENTIFIED FROM THE TRANSCRIPT
“Because people are going to use drugs recreationally. Again, that's luckily the way that these drugs are both most efficacious and safest is in the therapeutic container. And so, you know, my hope is certainly that that's what people focus on. But I don't want to deny that there are real risks with using these in an uncontrolled way.”
2024-01-18 · On with Kara Swisher · Psychedelics with Joe Green · IDENTIFIED FROM THE TRANSCRIPT